AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2018
Mar 2, 2018
30442_dirs_2018-03-02_5fe9e0e0-5280-4cbe-bac6-a11e31d31c1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2018-02-28
Reporting Person: EWALD STEPHEN P (General Counsel & Corp. Secy.)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | Employee Stock Option (Right to Buy) | $32.05 | A | 7500 | Acquired | 2025-02-28 | Common Stock (7500) | Direct |
Footnotes
F1: The option vests on February 28, 2022, subject to the Reporting Person's continued employment with the Issuer.
More from Medpace Holdings, Inc.
Board/Management Information
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18